Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance
Go back to Tarsus Pharmaceuticals, Inc. (TARS) Tops Q1 EPS by 14c, reaffirms product guidance| (NASDAQ: TARS) | Delayed: 61.80 -0.81 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.61 | 52 Week High | $ | |||
| Open | $62.70 | 52 Week Low | $ | |||
| Day High | $63.61 | P/E | N/A | |||
| Day Low | $61.71 | EPS | $ | |||
| Volume | 177,733 | |||||

